Atlas Trials

A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes

Clinical trial NCT03115099 · COMPLETED

Trial details

NCT number
NCT03115099
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2017-05-31
Primary completion
2018-04-05
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.